Sintered nanoparticles and use of the same against a virus
TW202034907A
Use of composition containing ferrous amino acid chelate particles for preparing pharmaceutical product for treating or slowing autoimmunity-related diseases
CN112168842A
Use of sintered particles for treating intestinal infections and for enhancing growth performance
TW201938152A
Use of ferrous amino acid chelate to treat infection by enteropathogen and to enhance growth performance
CN111655252A
Composition containing ferrous amino acid particles and application thereof in preparing medicine for treating or improving pancreas-related diseases
US2019314322A1
Use of ferrous amino acid chelate to treat infection by enteropathogen and to enhance growth performance
TW202023576A
Composition containing ferrous amino acid particles and its application used to prepare medicinal products for treating or improving pancreas-related diseases characterized in that the composition contains ferrous amino acid particles formed by sintering the ferrous amino acid chelation, wherein the average molecular weight of the ferrous amino acid chelation particles is from 1,500 Dalton to 600,000 Dalton
US2019274967A1
Sintered ferrous amino acid particles and use of the same against a virus
TW201938140A
Sintered ferrous amino acid particles and use of the same against a virus
TW201934130A
Use of ferrous amino acid chelate to increase calcium absorption and bond mass, and to treat osteoporosis
WO2019160500A1
Use of ferrous amino acid chelate to increase calcium absorption and bone mass, and to treat osteoporosis
TW201929873A
Use of composition containing ferrous amino acid chelate to manufacture pharmaceutical product for inhibiting angiogenesis wherein the pharmaceutical product may be easily introduced to effectively inhibit angiogenesis
US2020316113A1
Use of composition comprising ferrous amino acid chelate in manufacture of medicament for inhibiting angiogenesis
WO2018148922A1
Use of composition containing ferrous amino acid chelate for manufacturing medicament for treating dysfunction of liver
TWI612959B
Composition containing ferrous amine acid chelate for manufacturing pharmaceutical for treatment of abnormal liver function capable of improving liver function
TW201821074A
Use of a composition containing a ferrous amino acid chelate compound for the manufacture of a medicament for preventing cancer metastasis
CN110035747A
Composition containing Ferrous amino acid chelates is used to manufacture the purposes for the pharmaceuticals for preventing cancer metastasis
TWI587856B
Use of composition containing ferrous amino acid chelate for manufacture of medicament to reduce lactic acid produced by cancer capable of effectively reducing accumulation of lactic acid in cancer cells and reducing the glucose uptake
